Nurix Therapeutics Statistics
Total Valuation
NRIX has a market cap or net worth of $1.28 billion. The enterprise value is $698.93 million.
Important Dates
The next estimated earnings date is Wednesday, April 9, 2025, before market open.
Earnings Date | Apr 9, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
NRIX has 75.89 million shares outstanding. The number of shares has increased by 23.52% in one year.
Current Share Class | 75.89M |
Shares Outstanding | 75.89M |
Shares Change (YoY) | +23.52% |
Shares Change (QoQ) | +7.74% |
Owned by Insiders (%) | 0.62% |
Owned by Institutions (%) | 86.85% |
Float | 62.62M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 20.76 |
Forward PS | 24.55 |
PB Ratio | 2.43 |
P/TBV Ratio | 2.43 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 12.81 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.46, with a Debt / Equity ratio of 0.05.
Current Ratio | 6.46 |
Quick Ratio | 6.38 |
Debt / Equity | 0.05 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -53.22% and return on invested capital (ROIC) is -33.86%.
Return on Equity (ROE) | -53.22% |
Return on Assets (ROA) | -25.98% |
Return on Invested Capital (ROIC) | -33.86% |
Return on Capital Employed (ROCE) | -37.15% |
Revenue Per Employee | $190,731 |
Profits Per Employee | -$676,815 |
Employee Count | 286 |
Asset Turnover | 0.11 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, NRIX has paid $270,000 in taxes.
Income Tax | 270,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +67.20% in the last 52 weeks. The beta is 2.14, so NRIX's price volatility has been higher than the market average.
Beta (5Y) | 2.14 |
52-Week Price Change | +67.20% |
50-Day Moving Average | 19.25 |
200-Day Moving Average | 20.92 |
Relative Strength Index (RSI) | 35.92 |
Average Volume (20 Days) | 658,864 |
Short Selling Information
The latest short interest is 10.95 million, so 14.43% of the outstanding shares have been sold short.
Short Interest | 10.95M |
Short Previous Month | 10.87M |
Short % of Shares Out | 14.43% |
Short % of Float | 17.48% |
Short Ratio (days to cover) | 16.03 |
Income Statement
In the last 12 months, NRIX had revenue of $54.55 million and -$193.57 million in losses. Loss per share was -$2.88.
Revenue | 54.55M |
Gross Profit | -167.08M |
Operating Income | -213.03M |
Pretax Income | -164.82M |
Net Income | -193.57M |
EBITDA | -205.01M |
EBIT | -213.03M |
Loss Per Share | -$2.88 |
Full Income Statement Balance Sheet
The company has $609.58 million in cash and $28.30 million in debt, giving a net cash position of $581.28 million or $7.66 per share.
Cash & Cash Equivalents | 609.58M |
Total Debt | 28.30M |
Net Cash | 581.28M |
Net Cash Per Share | $7.66 |
Equity (Book Value) | 526.99M |
Book Value Per Share | 6.95 |
Working Capital | 523.53M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$172.58 million and capital expenditures -$9.27 million, giving a free cash flow of -$181.86 million.
Operating Cash Flow | -172.58M |
Capital Expenditures | -9.27M |
Free Cash Flow | -181.86M |
FCF Per Share | -$2.40 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -390.52% |
Pretax Margin | -354.36% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
NRIX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -23.52% |
Shareholder Yield | -23.52% |
Earnings Yield | -15.12% |
FCF Yield | -14.21% |
Analyst Forecast
The average price target for NRIX is $31.75, which is 88.20% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $31.75 |
Price Target Difference | 88.20% |
Analyst Consensus | Strong Buy |
Analyst Count | 16 |
Revenue Growth Forecast (5Y) | 52.13% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
NRIX has an Altman Z-Score of 2.87 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.87 |
Piotroski F-Score | 2 |